Total Payments
$330,523
2024 Payments
$6,795
Companies
23
Transactions
92
Medicare Patients
1,097
Medicare Billing
$111,297
Payment Breakdown by Category
Research$250,728 (75.9%)
Consulting$70,120 (21.2%)
Travel$5,886 (1.8%)
Food & Beverage$2,538 (0.8%)
Other$1,250 (0.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $250,728 | 6 | 75.9% |
| Consulting Fee | $70,120 | 26 | 21.2% |
| Travel and Lodging | $5,886 | 15 | 1.8% |
| Food and Beverage | $2,538 | 44 | 0.8% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $1,250 | 1 | 0.4% |
Payments by Type
Research
$250,728
6 transactions
General
$79,794
86 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AI Therapeutics, Inc. | $219,124 | 3 | $0 (2020) |
| LAM Therapeutics, Inc. | $30,239 | 1 | $0 (2017) |
| Kite Pharma, Inc. | $12,732 | 12 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $12,625 | 8 | $0 (2023) |
| ADC Therapeutics America, Inc. | $9,420 | 13 | $0 (2024) |
| Eli Lilly and Company | $8,424 | 4 | $0 (2021) |
| AbbVie Inc. | $5,537 | 7 | $0 (2023) |
| Celgene Corporation | $5,518 | 5 | $0 (2019) |
| Lilly USA, LLC | $5,360 | 8 | $0 (2022) |
| BeiGene USA, Inc. | $5,213 | 3 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $6,795 | 13 | ADC Therapeutics America, Inc. ($6,606) |
| 2023 | $15,610 | 14 | AstraZeneca Pharmaceuticals LP ($4,651) |
| 2022 | $11,278 | 17 | Lilly USA, LLC ($5,360) |
| 2021 | $12,235 | 9 | Kite Pharma, Inc. ($4,724) |
| 2020 | $78,896 | 4 | AI Therapeutics, Inc. ($72,071) |
| 2019 | $122,387 | 21 | AI Therapeutics, Inc. ($102,494) |
| 2018 | $46,105 | 5 | AI Therapeutics, Inc. ($44,559) |
| 2017 | $37,218 | 9 | LAM Therapeutics, Inc. ($30,239) |
All Payment Transactions
92 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/31/2024 | F. Hoffmann-La Roche AG | — | — | In-kind items and services | $158.67 | Research |
| Study: LEO DLBCL R R | ||||||
| 12/10/2024 | ADC Therapeutics America, Inc. | — | Consulting Fee | Cash or cash equivalent | $5,000.00 | General |
| 12/10/2024 | ADC Therapeutics America, Inc. | — | Food and Beverage | Cash or cash equivalent | $108.35 | General |
| 12/10/2024 | ADC Therapeutics America, Inc. | — | Travel and Lodging | Cash or cash equivalent | $49.06 | General |
| 09/27/2024 | ADC Therapeutics America, Inc. | — | Travel and Lodging | Cash or cash equivalent | $346.69 | General |
| 09/27/2024 | ADC Therapeutics America, Inc. | — | Food and Beverage | Cash or cash equivalent | $120.03 | General |
| 09/27/2024 | ADC Therapeutics America, Inc. | — | Food and Beverage | Cash or cash equivalent | $60.02 | General |
| 09/27/2024 | ADC Therapeutics America, Inc. | — | Food and Beverage | Cash or cash equivalent | $50.01 | General |
| 09/27/2024 | ADC Therapeutics America, Inc. | — | Food and Beverage | Cash or cash equivalent | $43.01 | General |
| 09/27/2024 | ADC Therapeutics America, Inc. | — | Food and Beverage | Cash or cash equivalent | $24.01 | General |
| 09/20/2024 | ADC Therapeutics America, Inc. | — | Travel and Lodging | Cash or cash equivalent | $86.00 | General |
| 09/19/2024 | ADC Therapeutics America, Inc. | — | Travel and Lodging | Cash or cash equivalent | $719.21 | General |
| 07/08/2024 | Tempus AI, Inc | — | Food and Beverage | In-kind items and services | $30.23 | General |
| 12/18/2023 | Kite Pharma, Inc. | Tecartus (Drug) | Consulting Fee | Cash or cash equivalent | $2,390.00 | General |
| Category: CELLT | ||||||
| 12/08/2023 | Pharmacyclics LLC, An AbbVie Company | VENCLEXTA (Drug) | Food and Beverage | In-kind items and services | $48.80 | General |
| Category: ONCOLOGY | ||||||
| 08/14/2023 | AbbVie Inc. | EPKINLY (Drug) | Consulting Fee | Cash or cash equivalent | $2,025.00 | General |
| Category: ONCOLOGY | ||||||
| 07/11/2023 | AstraZeneca Pharmaceuticals LP | LUMOXITI (Biological) | Consulting Fee | Cash or cash equivalent | $1,712.50 | General |
| Category: Oncology | ||||||
| 07/05/2023 | AstraZeneca Pharmaceuticals LP | CALQUENCE (Drug) | Consulting Fee | Cash or cash equivalent | $2,740.00 | General |
| Category: Oncology | ||||||
| 06/15/2023 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $110.35 | General |
| 06/14/2023 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $88.28 | General |
| 06/14/2023 | AbbVie Inc. | VENCLEXTA (Drug) | Food and Beverage | In-kind items and services | $7.39 | General |
| Category: ONCOLOGY | ||||||
| 06/13/2023 | BeiGene USA, Inc. | BRUKINSA (Drug) | Food and Beverage | In-kind items and services | $37.28 | General |
| Category: Oncology | ||||||
| 06/13/2023 | Genentech USA, Inc. | Polivy (Biological) | Food and Beverage | In-kind items and services | $36.80 | General |
| Category: BioOncology | ||||||
| 06/13/2023 | ADC Therapeutics America, Inc. | — | Food and Beverage | In-kind items and services | $13.45 | General |
| 03/30/2023 | BeiGene USA, Inc. | BRUKINSA (Drug) | Consulting Fee | Cash or cash equivalent | $2,250.00 | General |
| Category: Oncology | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| LAM 002A-NHL-CLN01 | AI Therapeutics, Inc. | $102,494 | 1 |
| LAM-002A-NHL-CLN01 | AI Therapeutics, Inc. | $72,071 | 1 |
| LAM 002A-NHL CLN01 | AI Therapeutics, Inc. | $44,559 | 1 |
| Treatment Patterns Outcomes and Patient Reported Quality of Life A Prospective Disease Registry of Patients with Mantle Cell Lymphoma Treated with Novel Agents | AstraZeneca Pharmaceuticals LP | $1,206 | 1 |
| LEO DLBCL R R | F. Hoffmann-La Roche AG | $158.67 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 252 | 341 | $137,408 | $20,560 |
| 2022 | 6 | 255 | 371 | $136,199 | $25,389 |
| 2021 | 8 | 297 | 475 | $168,336 | $34,105 |
| 2020 | 7 | 293 | 542 | $153,650 | $31,243 |
Total Patients
1,097
Total Services
1,729
Medicare Billing
$111,297
Procedure Codes
25
All Medicare Procedures & Services
25 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 144 | 187 | $59,435 | $8,482 | 14.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 71 | 116 | $51,156 | $7,896 | 15.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 24 | 24 | $18,159 | $2,818 | 15.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 13 | 14 | $8,658 | $1,365 | 15.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 68 | 99 | $41,490 | $6,788 | 16.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 101 | 122 | $36,157 | $5,742 | 15.9% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 20 | 48 | $15,648 | $3,937 | 25.2% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 25 | 25 | $17,898 | $3,454 | 19.3% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 21 | 56 | $12,739 | $3,195 | 25.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 20 | 21 | $12,267 | $2,272 | 18.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 84 | 133 | $50,595 | $9,658 | 19.1% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 43 | 43 | $30,183 | $6,128 | 20.3% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 21 | 90 | $20,790 | $5,186 | 24.9% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 29 | 41 | $21,715 | $4,647 | 21.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 81 | 95 | $25,340 | $3,881 | 15.3% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 14 | 36 | $12,165 | $2,898 | 23.8% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 11 | 12 | $4,257 | $960.02 | 22.6% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2021 | 14 | 25 | $3,291 | $746.31 | 22.7% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 50 | 194 | $44,533 | $11,185 | 25.1% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 115 | 183 | $44,580 | $6,629 | 14.9% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Office | 2020 | 34 | 34 | $23,099 | $4,580 | 19.8% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 18 | 41 | $13,444 | $3,514 | 26.1% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 43 | 51 | $18,186 | $2,897 | 15.9% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2020 | 20 | 21 | $7,360 | $1,854 | 25.2% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2020 | 13 | 18 | $2,448 | $582.65 | 23.8% |
About Dr. Jonathon Cohen, M.D
Dr. Jonathon Cohen, M.D is a Hematology & Oncology healthcare provider based in Atlanta, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/28/2007. The National Provider Identifier (NPI) number assigned to this provider is 1902003403.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jonathon Cohen, M.D has received a total of $330,523 in payments from pharmaceutical and medical device companies, with $6,795 received in 2024. These payments were reported across 92 transactions from 23 companies. The most common payment nature is "" ($250,728).
As a Medicare-enrolled provider, Cohen has provided services to 1,097 Medicare beneficiaries, totaling 1,729 services with total Medicare billing of $111,297. Data is available for 4 years (2020–2023), covering 25 distinct procedure/service records.
Ad
Practice Information
- Specialty Hematology & Oncology
- Other Specialties Student in an Organized Health Care Education/Training Program, Hematology & Oncology
- Location Atlanta, GA
- Active Since 06/28/2007
- Last Updated 02/25/2021
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1902003403
Products in Payments
- CALQUENCE (Drug) $10,714
- Tecartus (Drug) $7,114
- IMBRUVICA (Drug) $6,095
- Revlimid (Drug) $5,518
- BRUKINSA (Drug) $5,213
- Rituxan (Biological) $4,947
- EPKINLY (Drug) $3,375
- LUMOXITI (Biological) $1,713
- clonoSEQ (Device) $1,500
- ADCETRIS (Biological) $1,250
- Senza Spinal Cord Stimulation System (Device) $143.75
- VENCLEXTA (Drug) $132.98
- Yescarta (Drug) $124.92
- JAKAFI (Drug) $51.57
- Polivy (Biological) $36.80
- GAZYVA (Biological) $26.80
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Atlanta
Dr. Ajay Nooka, M.d., M.p.h.,F.a.c.p, M.D., M.P.H.,F.A.C.P
Hematology & Oncology — Payments: $256,358
Hematology & Oncology $256,358
Dr. Rodolfo Bordoni, Md, MD
Hematology & Oncology — Payments: $240,507
Hematology & Oncology $240,507
Dr. Mehmet Bilen, M.d, M.D
Hematology & Oncology — Payments: $134,196
Hematology & Oncology $134,196
Olatunji Alese, M.d, M.D
Hematology & Oncology — Payments: $131,083
Hematology & Oncology $131,083
Dr. Carlos Franco, Md, MD
Hematology & Oncology — Payments: $115,439
Hematology & Oncology $115,439
Fuad El Rassi, M.d, M.D
Hematology & Oncology — Payments: $96,080
Hematology & Oncology $96,080